These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 35233882)
1. LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and cell model. Zhang L; Cai Y; Tian C; Li Y; Ma K; Gao X; Liu L; Jiang Y; Wen W; Ma Z J Obstet Gynaecol Res; 2022 May; 48(5):1222-1232. PubMed ID: 35233882 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA OPA-interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR-143-3p. Chen X; Xiong D; Yang H; Ye L; Mei S; Wu J; Chen S; Shang X; Wang K; Huang L J Cell Physiol; 2019 Apr; 234(4):5264-5275. PubMed ID: 30341904 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer. Yang J; Jiang B; Hai J; Duan S; Dong X; Chen C J Cell Biochem; 2019 Jan; 120(1):907-916. PubMed ID: 30188591 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6. Wang Y; Li L; Zhang X; Zhao X J Ovarian Res; 2022 Feb; 15(1):25. PubMed ID: 35168644 [TBL] [Abstract][Full Text] [Related]
5. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137. Liang J; Tian XF; Yang W World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression. Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653 [TBL] [Abstract][Full Text] [Related]
8. OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer. Shi C; Zhang H; Wang M; Tian R; Li X; Feng Y; Peng F; Qin R Dig Dis Sci; 2022 Mar; 67(3):915-924. PubMed ID: 33782807 [TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines. Guan MM; Rao QX; Huang ML; Wang LJ; Lin SD; Chen Q; Liu CH Med Sci Monit; 2019 Oct; 25():8131-8141. PubMed ID: 31663517 [TBL] [Abstract][Full Text] [Related]
10. lncRNA OIP5-AS1 targets ROCK1 to promote cell proliferation and inhibit cell apoptosis through a mechanism involving miR-143-3p in cervical cancer. Song L; Wang L; Pan X; Yang C Braz J Med Biol Res; 2020; 53(1):e8883. PubMed ID: 31939597 [TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA ZEB1-Antisense 1 Affects Cell Migration and Invasion of Cervical Cancer by Regulating Epithelial-Mesenchymal Transition via the p38MAPK Signaling Pathway. Gan L; Chen Y; Liu H; Ju WH Gynecol Obstet Invest; 2019; 84(2):136-144. PubMed ID: 30253398 [TBL] [Abstract][Full Text] [Related]
12. LncRNA OIP5-AS1 Promotes Breast Cancer Progression by Regulating miR-216a-5p/GLO1. Wu Z; Liu Y; Wei L; Han M J Surg Res; 2021 Jan; 257():501-510. PubMed ID: 32916503 [TBL] [Abstract][Full Text] [Related]
13. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA Opa interacting protein 5-antisense RNA 1 promotes mitochondrial autophagy and protects SH-SY5Y cells from 1-methyl-4-phenylpyridine-induced damage by binding to microRNA-137 and upregulating NIX. Zhao Y; Xie Y; Yao WY; Wang YY; Song N Kaohsiung J Med Sci; 2022 Mar; 38(3):207-217. PubMed ID: 35049152 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway. Meng X; Ma J; Wang B; Wu X; Liu Z J Physiol Biochem; 2020 May; 76(2):301-315. PubMed ID: 32157498 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p. Wang M; Sun X; Yang Y; Jiao W Thorac Cancer; 2018 Aug; 9(8):939-949. PubMed ID: 29897167 [TBL] [Abstract][Full Text] [Related]
17. LncRNA OIP5-AS1 induces epithelial-to-mesenchymal transition and renal fibrosis in diabetic nephropathy via binding to miR-30c-5p. Fu JX; Sun GQ; Wang HL; Jiang HX J Biol Regul Homeost Agents; 2020; 34(3):961-968. PubMed ID: 32519534 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor. Feng K; Liu Y; Xu LJ; Zhao LF; Jia CW; Xu MY Biomed Pharmacother; 2018 Aug; 104():686-698. PubMed ID: 29803929 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of long non-coding RNA Opa interacting protein 5-antisense RNA 1 inhibits breast cancer progression by targeting sex-determining region Y-box 2 by microRNA-129-5p upregulation. Zeng H; Wang J; Chen T; Zhang K; Chen J; Wang L; Li H; Tuluhong D; Li J; Wang S Cancer Sci; 2019 Jan; 110(1):289-302. PubMed ID: 30443959 [TBL] [Abstract][Full Text] [Related]
20. LMCD1-AS1 Facilitates Cell Proliferation and EMT by Sponging miR-873-3p in Cervical Cancer. Liang M; Li Y; Chen C Crit Rev Eukaryot Gene Expr; 2023; 33(2):13-25. PubMed ID: 36734854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]